|
Maroteaux-Lamy Syndrome: See MPS VI Mitral Valve Prolapse: Flaps between 2 parts of the heart, the left atrium and the left ventricle, don't close evenly allowing a small amount of blood to leak back into the left atrium.
ML II: Also called I-Cell Disease, caused by a deficiency of the lysosomal enzyme N-acetylglucosaminyl-1-phosphotransferase. Autosomal recessive disease characterized by severe psychomotor retardation and by many of the clinical features seen in severe MPS I.
ML III: Also called Pseudo-Hurler Polydystrophy, caused by a deficiency of the lysosomal enzyme N-acetylglucosaminyl-1-phosphotransferase. Autosomal recessive disease with less severe disease course than ML II, presenting later in life with survival into adulthood.
Morquio Syndrome: See MPS IV
MPS I: Also called Hurler, Hurler-Scheie and Scheie, caused by a deficiency of the lysosomal enzyme a-L-Iduronidase. Autosomal recessive, heterogeneous disease characterized by a wide range of clinical involvement, including corneal clouding, bone changes, stiff joints, large liver and spleen, and heart disease.
MPS II: Also called Hunter syndrome, caused by a deficiency of the lysosomal enzyme Iduronate sulfatase. X-linked recessive, heterogeneous disease characterized by a wide range of clinical involvement, including large liver and spleen, stiff joints, bone changes, and heart disease.
MPS III: Also called Sanfilippo syndrome, an autosomal recessive disease classified into 4 types based on the enzyme deficiency. The features in each type are similar and characterized by severe central nervous system degeneration but only mild somatic (relating to the body) problems.
MPS III-A: Caused by a deficiency of the lysosomal enzyme Heparan N-sulfatase.
MPS III-B: Caused by a deficiency of the lysosomal enzyme a-N-Acetylglucosamnidase.
MPS III-C: Caused by a deficiency of the lysosomal enzyme Acetyl CoA: a-glucosaminide acetyltransferase.
MPS III-D: Caused by a deficiency of the lysosomal enzyme N-acetyl glucosamine 6-sulfatase.
MPS IV: Also called Morquio syndrome, autosomal recessive disease classified into 2 types based on the enzyme deficiency, each with a wide range of clinical manifestations. Both types are characterized by short trunk dwarfism, fine corneal deposits and preservation of intelligence.
MPS IV-A: Caused by a deficiency of the lysosomal enzyme Galactose 6-sulfatase.
MPS IV-B: Caused by a deficiency of the lysosomal enzyme b-Galactosidase.
MPS VI: Also called Maroteaux-Lamy syndrome, caused by a deficiency of the lysosomal enzyme arylsulfatase B. Autosomal recessive disease with bone abnormalities, corneal clouding and normal intelligence.
MPS VII: Also called Sly syndrome, caused by a deficiency of the lysosomal enzyme b-Glucuronidase. Autosomal recessive disease characterized by large liver and spleen, bone abnormalities and a wide spectrum of severity.
MPS IX: An autosomal recessive disease, caused by a deficiency of the lysosomal enzyme Hyalurondiase, characterized by short stature, soft-tissue masses and normal joint movement and intelligence.
Mucolipidosis: Term coined to denote diseases that combined clinical features common to both the mucopolysaccharidoses and the sphingolipidoses (diseases characterized by abnormal lipid or fat metabolism, affecting nerve tissue). See ML II and ML III
Mucopolysaccharide: A complex carbohydrate molecule that is a common constituent of secretions and the connective tissue between cells. Although the molecules were originally called "mucopolysaccharides" because of their ability to form viscous, mucin-like solutions, the terminology was revised to "proteoglycans" and subsequently to "glycosaminoglycans" in the last decades.
Mutation: A change in the genetic material (DNA) of a cell that alters expected genetic processes.
|